Quanex Building Products ... (NX)
NYSE: NX
· Real-Time Price · USD
18.58
1.34 (7.77%)
At close: May 12, 2025, 12:22 PM
Quanex Building Products Revenue Breakdown
| Period Ending | Oct 31, 2024 | Oct 31, 2023 | Oct 31, 2022 | Oct 31, 2021 | Oct 31, 2020 | Oct 31, 2019 | Oct 31, 2018 | Oct 31, 2017 | Oct 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|
| EU Engineered Components Revenue | 230.71M | 250.77M | 262.06M | 251.6M | 161.05M | 165M | 159.97M | 147.96M | 150.2M |
| EU Engineered Components Revenue Growth | -8.00% | -4.31% | +4.16% | +56.22% | -2.39% | +3.14% | +8.12% | -1.49% | n/a |
| NA Engineered Components Revenue | 650.06M | 667.48M | 687.46M | 578.33M | 483.42M | 503.84M | 249.81M | 248.81M | 223.39M |
| NA Engineered Components Revenue Growth | -2.61% | -2.91% | +18.87% | +19.63% | -4.05% | +101.69% | +0.40% | +11.38% | n/a |
| NA Cabinet Components Revenue | 198.42M | 215.44M | 275.7M | 246.07M | 210.1M | 229.64M | 485.37M | 474.88M | 560.03M |
| NA Cabinet Components Revenue Growth | -7.90% | -21.86% | +12.04% | +17.12% | -8.51% | -52.69% | +2.21% | -15.20% | n/a |
Operating Expense Breakdown
| Period Ending | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 | Apr 30, 2020 | Jan 31, 2020 | Oct 31, 2019 | Jul 31, 2019 | Apr 30, 2019 | Jan 31, 2019 | Oct 31, 2018 | Jul 31, 2018 | Apr 30, 2018 | Jan 31, 2018 | Oct 31, 2017 | Jul 31, 2017 | Apr 30, 2017 | Jan 31, 2017 | Oct 31, 2016 | Jul 31, 2016 | Apr 30, 2016 | Jan 31, 2016 | Oct 31, 2015 | Jul 31, 2015 | Apr 30, 2015 | Jan 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 66.65M | 86.89M | 36.51M | 34.71M | 32.36M | 29.33M | 30.52M | 27.37M | 36.74M | 29.33M | 28.82M | 28.13M | 30.82M | 27.67M | 27.77M | 29.67M | 30.86M | 26.89M | 21.97M | 16.71M | 24.13M | 23.83M | 25.72M | 23.72M | 28.03M | 31.49M | 24.19M | 23.78M | 24.08M | 23.14M | 20.48M | 26.92M | 27.45M | 26.48M | 28.55M | 28.59M | 31.29M | 22.38M | 25.02M | 19.64M | 19.5M |
| Selling, General, and Administrative Revenue Growth | -23.29% | +138.00% | +5.19% | +7.24% | +10.36% | -3.90% | +11.49% | -25.51% | +25.26% | +1.78% | +2.46% | -8.74% | +11.40% | -0.35% | -6.42% | -3.85% | +14.77% | +22.37% | +31.47% | -30.74% | +1.28% | -7.36% | +8.41% | -15.36% | -10.99% | +30.16% | +1.71% | -1.22% | +4.04% | +13.01% | -23.92% | -1.93% | +3.64% | -7.25% | -0.14% | -8.62% | +39.81% | -10.57% | +27.42% | +0.73% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |